Contact
searchSearch
HMP Global

Volume 27 - Issue 3 - March, 2015

Letters to the Editor
Is the Evaluation Sufficient? Interpretation on the Cardiac Inhomogeneity Without Considering the Transmural Dispersion
02/24/2015
Omer Yiginer, MD; Abdullah Haholu, MD; Mehmet Tezcan, MD; Namik Ozmen, MD
The authors opine on a previous study by Mirbolouk et al (J Invasive Cardiol. 2014;26(9):444-450) and recommend the addition of transmural dispersion data to the study to reveal the effects of revascularization procedures on electrical...
The authors opine on a previous study by Mirbolouk et al (J Invasive Cardiol. 2014;26(9):444-450) and recommend the addition of transmural dispersion data to the study to reveal the effects of revascularization procedures on electrical...
The authors opine on a previous...
02/24/2015
Journal of Invasive Cardiology
Invasive Thoughts
Interventional Cardiology: Reflections on My Career Choice at 10 Years
02/24/2015
Srihari S. Naidu, MD
Dr Naidu offers his thoughts on the state of Interventional Cardiology after a decade in practice.
Dr Naidu offers his thoughts on the state of Interventional Cardiology after a decade in practice.
Dr Naidu offers his thoughts on...
02/24/2015
Journal of Invasive Cardiology
Intravascular-Ultrasound Assisted Localization and Revascularization of an Ostial Chronic Total Occlusion: Utility of Near-Field and Far-Field Imaging
02/24/2015
Eric L. Wallace, DO; Khaled M. Ziada, MD
We demonstrate the utility of intravascular ultrasound imaging in the localization of an ambiguous or “stump-less” ostial CTO in addition to providing real-time far-field imaging, which is helpful in tracking wire progress through the...
We demonstrate the utility of intravascular ultrasound imaging in the localization of an ambiguous or “stump-less” ostial CTO in addition to providing real-time far-field imaging, which is helpful in tracking wire progress through the...
We demonstrate the utility of...
02/24/2015
Journal of Invasive Cardiology
Percutaneous Transcatheter Balloon Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis in a patient With Orthotopic Heart Transplant
02/24/2015
Nikolaos Kakouros, MBBS, PhD, MRCP, MD(Res); Jeffrey Shih, MD; Gaurav Rana, MBBS
A 47-year-old man with history of familial cardiomyopathy and orthotopic heart transplant at the age of 34 years presented severe tricuspid stenosis (TS) with a mean transvalvular gradient of 10 mm Hg. To the best of our knowledge, this is...
A 47-year-old man with history of familial cardiomyopathy and orthotopic heart transplant at the age of 34 years presented severe tricuspid stenosis (TS) with a mean transvalvular gradient of 10 mm Hg. To the best of our knowledge, this is...
A 47-year-old man with history...
02/24/2015
Journal of Invasive Cardiology
Original Contribution
A Prospective, Randomized, Pivotal Trial of a Novel Extravascular Collagen-Based Closure Device Compared to Manual Compression in Diagnostic and Interventional Patients
02/24/2015
Nick Cavros, MD; Nilesh J. Goswami, MD; Wayne Leimbach, MD; Roger Gammon, MD; Steven P. Karas, MD; John McCabe, MD; Richard Paulus, MD; James B. Hermiller, MD, FACC, MSCAI; Zoltan G. Turi, MD; Shing-Chiu Wong, MD; Srihari S. Naidu, MD; Robert J. Whitbourn, MD, MBBS
The RESPECT trial was a multicenter, randomized comparison that evaluates the safety/efficacy of the new Vascade extravascular closure system (Cardiva Medical, Inc) in diagnostic and interventional procedures. Compared to manual compression,...
The RESPECT trial was a multicenter, randomized comparison that evaluates the safety/efficacy of the new Vascade extravascular closure system (Cardiva Medical, Inc) in diagnostic and interventional procedures. Compared to manual compression,...
The RESPECT trial was a...
02/24/2015
Journal of Invasive Cardiology
Commentary
Commentary: Where Are We With Vascular Closure Devices After Percutaneous Arteriotomy?
02/24/2015
Marc S. Cohen, MD
A discussion of the RESPECT trial results, and potential issues involved in achieving hemostasis with the new Vascade extravascular closure system (Cardiva Medical, Inc) is provided. While there is no formal economic analysis, Dr. Cohen...
A discussion of the RESPECT trial results, and potential issues involved in achieving hemostasis with the new Vascade extravascular closure system (Cardiva Medical, Inc) is provided. While there is no formal economic analysis, Dr. Cohen...
A discussion of the RESPECT...
02/24/2015
Journal of Invasive Cardiology
Original Contribution
Adoption of the Hybrid CTO Approach by a Single Non-CTO Operator: Procedural and Clinical Outcomes
02/24/2015
John Ducas, MD; James M. McCabe, MD, FACC; Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; William L. Lombardi, MD; Amir Ravandi, MD, PhD; Minh N. Vo, MD
This study tested the feasibility of adopting the “hybrid” approach by a single operator without prior experience in CTO-PCI. The authors conclude that the “hybrid” approach to CTO-PCI can be successfully adopted by a single operator with...
This study tested the feasibility of adopting the “hybrid” approach by a single operator without prior experience in CTO-PCI. The authors conclude that the “hybrid” approach to CTO-PCI can be successfully adopted by a single operator with...
This study tested the...
02/24/2015
Journal of Invasive Cardiology
Commentary
Commentary: CTO-PCI: An Emerging New Subspecialty in Interventional Cardiology
02/24/2015
Dimitrios Karmpaliotis, MD, PhD; Philip Green, MD
CTO-PCI has emerged as a new subspecialty of interventional cardiology; modern CTO operators have set a new benchmark for CTO success rates of above 90%. With appropriate training and dissemination of the hybrid approach to new operators in...
CTO-PCI has emerged as a new subspecialty of interventional cardiology; modern CTO operators have set a new benchmark for CTO success rates of above 90%. With appropriate training and dissemination of the hybrid approach to new operators in...
CTO-PCI has emerged as a new...
02/24/2015
Journal of Invasive Cardiology
Original Contribution
Clinical and Economic Effectiveness of Percutaneous Ventricular Assist Devices for High-Risk Patients Undergoing Percutaneous Coronary Intervention
02/24/2015
Karin E. Dill, MD; Joseph L. Thomas, MD, FACC, FSCAI; Jonathan D. Paul, MD; Sandeep Nathan, MD, MSc, FACC, FSCAI; Atman P. Shah, MD, FACC, FSCAI; Elizabeth M. Retzer, MD; Janet Friant, MSN, APN
This study conducted a review of all comparative randomized control trials of the pVADS (Impella and TandemHeart) vs IABP for patients undergoing high-risk percutaneous coronary intervention (PCI).
This study conducted a review of all comparative randomized control trials of the pVADS (Impella and TandemHeart) vs IABP for patients undergoing high-risk percutaneous coronary intervention (PCI).
This study conducted a review of...
02/24/2015
Journal of Invasive Cardiology
Commentary
Commentary: Intraaortic Balloon Pump Versus Percutaneous Ventricular Assist for the High-Risk Patient: Keep it Simple Except When You Can`t
02/24/2015
Sheldon Goldberg, MD, FACC, FSCAI; Mary Shields, MD
In order to put the pVAD analysis of Shah et al into clinical perspective, Drs Shields and Goldberg review the definitions of “high-risk PCI,” the mechanism of action of support devices for PCI patients, and comment on the results of trials...
In order to put the pVAD analysis of Shah et al into clinical perspective, Drs Shields and Goldberg review the definitions of “high-risk PCI,” the mechanism of action of support devices for PCI patients, and comment on the results of trials...
In order to put the pVAD...
02/24/2015
Journal of Invasive Cardiology

News

HeartFlow Plaque Analysis
plaque analysis
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
09/22/2025
Heartflow also announced that Heartflow Plaque Analysis will be covered by Cigna across all of its lines of business, including Commercial and Medicare Advantage plans, beginning in October.
Heartflow also announced that Heartflow Plaque Analysis will be covered by Cigna across all of its lines of business, including Commercial and Medicare Advantage plans, beginning in October.
Heartflow also announced that...
09/22/2025
Cath Lab Digest
Cardiogenic Shock
New SCAI Initiative Targets Faster Shock Diagnosis and Care with ‘Door to Lactate Clearance’
09/19/2025
“SCAI Door to Lactate Clearance (SCAI DLC) Cardiogenic Shock Initiative: Definition, Hypothesis and Call to Action” was unveiled September 19 at the SCAI SHOCK Conference in Tampa, FL, with simultaneous publication in JSCAI.  
“SCAI Door to Lactate Clearance (SCAI DLC) Cardiogenic Shock Initiative: Definition, Hypothesis and Call to Action” was unveiled September 19 at the SCAI SHOCK Conference in Tampa, FL, with simultaneous publication in JSCAI.  
“SCAI Door to Lactate Clearance...
09/19/2025
Cath Lab Digest
Hyperkalemia
AccurKardia Announces Clinical Pilot Study of Its AK+ Guard ECG-based, AI-powered Hyperkalemia Detection Software
09/18/2025
Hyperkalemia, or an excess of serum potassium in the blood, is a common condition affecting patients with chronic kidney disease (CKD), end stage renal disease, and heart failure that can result in dangerous arrhythmias and sudden cardiac...
Hyperkalemia, or an excess of serum potassium in the blood, is a common condition affecting patients with chronic kidney disease (CKD), end stage renal disease, and heart failure that can result in dangerous arrhythmias and sudden cardiac...
Hyperkalemia, or an excess of...
09/18/2025
Cath Lab Digest
Patient Care
Hitting the Right Note: The Healing Power of Music Therapy in the Cardiac ICU
09/18/2025
Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking...
Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking...
Music therapy could...
09/18/2025
Cath Lab Digest
Pulmonary Embolism
Imperative Care Announces Late-Breaking Data Presentation and Peer-Reviewed Publication from Pivotal Trial of Symphony Thrombectomy System in Patients with Acute Pulmonary Embolism
09/18/2025
The Symphony Thrombectomy System is an aspiration catheter system engineered to deliver more efficient and effective clot removal in patients with venous thromboembolism (VTE). Symphony uniquely combines large-bore power with precise deep...
The Symphony Thrombectomy System is an aspiration catheter system engineered to deliver more efficient and effective clot removal in patients with venous thromboembolism (VTE). Symphony uniquely combines large-bore power with precise deep...
The Symphony Thrombectomy System...
09/18/2025
Cath Lab Digest
CVD
Cardiovascular Disease Risk Rises in Mexico, Despite Improved Cholesterol Control
09/18/2025
Despite improved statin use and cholesterol control, cardiovascular disease risk rose in Mexico between 2016 and 2023, according to a study being presented at ACC Latin America 2025 that used region-specific tools to more accurately predict...
Despite improved statin use and cholesterol control, cardiovascular disease risk rose in Mexico between 2016 and 2023, according to a study being presented at ACC Latin America 2025 that used region-specific tools to more accurately predict...
Despite improved statin use and...
09/18/2025
Cath Lab Digest
Thrombectomy
Penumbra's Lightning Bolt 6X with Trax Now Available in 150 cm, Bringing the Power of CAVT to More Distal Anatomy Below the Knee
09/16/2025
“Lightning Bolt 6X with TraX has been highly effective in addressing smaller embolized fragments in the AT,” says Dr. Visharad Patel at Wellstar North Fulton Hospital in Roswell, GA. “We have been impressed with its ability to navigate...
“Lightning Bolt 6X with TraX has been highly effective in addressing smaller embolized fragments in the AT,” says Dr. Visharad Patel at Wellstar North Fulton Hospital in Roswell, GA. “We have been impressed with its ability to navigate...
“Lightning Bolt 6X with TraX has...
09/16/2025
Cath Lab Digest
Heart Failure
ELEVATE-HFpEF: Medtronic Initiates Global Pivotal Study of Cardiac Pacing in New Patient Population
09/16/2025
Participants will either receive a pacemaker programmed with an elevated, personalized pacing rate, or one programmed to provide a non-personalized backup pacing rate if needed.
Participants will either receive a pacemaker programmed with an elevated, personalized pacing rate, or one programmed to provide a non-personalized backup pacing rate if needed.
Participants will either receive...
09/16/2025
Cath Lab Digest
Peripheral IVL
Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter Launched in Europe to Transform Treatment of Difficult-to-Cross Calcified Lesions
09/16/2025
“The Shockwave Javelin Peripheral IVL catheter helps address one of the most persistent technical barriers in complex below the knee (BTK) revascularization – the ‘device-uncrossable’ calcified lesion,” said Dr. Narayanan Thulasidasan
“The Shockwave Javelin Peripheral IVL catheter helps address one of the most persistent technical barriers in complex below the knee (BTK) revascularization – the ‘device-uncrossable’ calcified lesion,” said Dr. Narayanan Thulasidasan
“The Shockwave Javelin...
09/16/2025
Cath Lab Digest
Dr. Annapoorna Kini (left) and her team outside of The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab
AI Research
Mount Sinai Launches Cardiac Catheterization Artificial Intelligence Research Lab
09/16/2025
Annapoorna Kini, MD, will serve as Director of The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab. The new lab will focus on many aspects of interventional cardiology, from procedural to educational.
Annapoorna Kini, MD, will serve as Director of The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab. The new lab will focus on many aspects of interventional cardiology, from procedural to educational.
Annapoorna Kini, MD, will serve...
09/16/2025
Cath Lab Digest

Sovari Figure 1
Clinical Videos
Leadless Pacemaker Placement Through the Subclavian Vein: An Alternative to the Femoral Route
09/26/2025
Video Supplement to "Leadless Pacemaker Placement Through the Subclavian Vein: An Alternative to the Femoral Route" (Clinical Image).
Video Supplement to "Leadless Pacemaker Placement Through the Subclavian Vein: An Alternative to the Femoral Route" (Clinical Image).
Video Supplement to "Leadless...
09/26/2025
Journal of Invasive Cardiology
Clinical Images
Leadless Pacemaker Placement Through the Subclavian Vein: An Alternative to the Femoral Route
09/26/2025
09/26/2025
Journal of Invasive Cardiology
Brief Communication
Aortic Valve Calcification Alone Identifies Transcatheter Aortic Valve Replacement Benefit in Classical Low-Flow, Low-Gradient Aortic Stenosis
09/25/2025
The authors sought to determine if the prognostic relevance of aortic valve calcification differs by low-flow, low-gradient aortic stenosis subtype.
The authors sought to determine if the prognostic relevance of aortic valve calcification differs by low-flow, low-gradient aortic stenosis subtype.
The authors sought to determine...
09/25/2025
Journal of Invasive Cardiology
Offiah Figure
Clinical Videos
A Kissing WATCHMAN Approach to Bilobar Left Atrial Appendage Occlusion
09/24/2025
Video Supplement to "A Kissing WATCHMAN Approach to Bilobar Left Atrial Appendage Occlusion" (Clinical Image).
Video Supplement to "A Kissing WATCHMAN Approach to Bilobar Left Atrial Appendage Occlusion" (Clinical Image).
Video Supplement to "A Kissing...
09/24/2025
Journal of Invasive Cardiology
Clinical Images
A Kissing WATCHMAN Approach to Bilobar Left Atrial Appendage Occlusion
09/24/2025
An 83-year-old man with a history of atrial fibrillation presented with a subdural hematoma. His apixaban was stopped and a pacemaker was implanted.
An 83-year-old man with a history of atrial fibrillation presented with a subdural hematoma. His apixaban was stopped and a pacemaker was implanted.
An 83-year-old man with a...
09/24/2025
Journal of Invasive Cardiology
Casazza headshot
Author Interview
Ocular Radiation Exposure of the Primary Operator Performing Selective Coronary Angiography From a Radial Artery Approach
09/23/2025
Richard Casazza, MAS
Dr Richard Casazza shares background and insights on his article, "Ocular Radiation Exposure of the Primary Operator Performing Selective Coronary Angiography From a Radial Artery Approach."
Dr Richard Casazza shares background and insights on his article, "Ocular Radiation Exposure of the Primary Operator Performing Selective Coronary Angiography From a Radial Artery Approach."
Dr Richard Casazza shares...
09/23/2025
Journal of Invasive Cardiology
HeartFlow Plaque Analysis
plaque analysis
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
09/22/2025
Heartflow also announced that Heartflow Plaque Analysis will be covered by Cigna across all of its lines of business, including Commercial and Medicare Advantage plans, beginning in October.
Heartflow also announced that Heartflow Plaque Analysis will be covered by Cigna across all of its lines of business, including Commercial and Medicare Advantage plans, beginning in October.
Heartflow also announced that...
09/22/2025
Cath Lab Digest
Cardiogenic Shock
New SCAI Initiative Targets Faster Shock Diagnosis and Care with ‘Door to Lactate Clearance’
09/19/2025
“SCAI Door to Lactate Clearance (SCAI DLC) Cardiogenic Shock Initiative: Definition, Hypothesis and Call to Action” was unveiled September 19 at the SCAI SHOCK Conference in Tampa, FL, with simultaneous publication in JSCAI.  
“SCAI Door to Lactate Clearance (SCAI DLC) Cardiogenic Shock Initiative: Definition, Hypothesis and Call to Action” was unveiled September 19 at the SCAI SHOCK Conference in Tampa, FL, with simultaneous publication in JSCAI.  
“SCAI Door to Lactate Clearance...
09/19/2025
Cath Lab Digest
Hyperkalemia
AccurKardia Announces Clinical Pilot Study of Its AK+ Guard ECG-based, AI-powered Hyperkalemia Detection Software
09/18/2025
Hyperkalemia, or an excess of serum potassium in the blood, is a common condition affecting patients with chronic kidney disease (CKD), end stage renal disease, and heart failure that can result in dangerous arrhythmias and sudden cardiac...
Hyperkalemia, or an excess of serum potassium in the blood, is a common condition affecting patients with chronic kidney disease (CKD), end stage renal disease, and heart failure that can result in dangerous arrhythmias and sudden cardiac...
Hyperkalemia, or an excess of...
09/18/2025
Cath Lab Digest
Patient Care
Hitting the Right Note: The Healing Power of Music Therapy in the Cardiac ICU
09/18/2025
Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking...
Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking...
Music therapy could...
09/18/2025
Cath Lab Digest

March 2015 Volume 27 Issue 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use